Headquartered in Hayward, California, Intarcia Therapeutics is a force to be reckoned with in the biotech world. It has raised over $1 billion in total equity funding and recently acquired Phoundry Pharmaceuticals for an undisclosed amount.
It hasn’t gone public.
Cambridge, Massachusetts-based Moderna Therapeutics is another fine example. Founded in 2010, it has raised $1.1 billion in five rounds of private and corporate financing. Two of those investment rounds totaled $450 million and $474 million respectively — an industry record.
